| RS139244400 |
TIE1
|
Health Risk |
Pathogenic |
Lymphatic malformation 11, Lymphatic malformation 11 |
| RS139244736 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS1392447890 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS139245086 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1392467818 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1392470365 |
RPS7
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia 8, Diamond-Blackfan anemia 8 |
| RS139247073 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS139249329 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1392500142 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS139250920 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA4-related disorder, Retinal dystrophy |
| RS139251285 |
SLC3A1
|
Health Risk |
Pathogenic |
Cystinuria, Cystinuria |
| RS1392513631 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS139251660 |
RBFOX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Idiopathic generalized epilepsy |
| RS139251833 |
PDE6C
|
Health Risk |
Likely pathogenic |
— |
| RS1392520466 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS139252433 |
PUS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139252608 |
KIDINS220
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, KIDINS220-related disorder |
| RS139252668 |
FERMT1
|
Health Risk |
Pathogenic |
— |
| RS1392533284 |
EPAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Erythrocytosis |
| RS139253468 |
WWOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive spinocerebellar ataxia 12, Developmental and epileptic encephalopathy |
| RS1392541002 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS139254288 |
ATAD3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Harel-Yoon syndrome |
| RS139254363 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, MYOT-related disorder |
| RS139254423 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemolytic uremic syndrome, atypical |
| RS139254595 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group P |
| RS1392550887 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS139255481 |
IMPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS1392559810 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS139256741 |
PIGQ
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139257219 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1392582030 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS139258331 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Lissencephaly 9 with complex brainstem malformation |
| RS139258361 |
EPS8
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness, Inborn genetic diseases |
| RS139258703 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1392596033 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1392596720 |
MTX2
|
Health Risk |
Pathogenic |
Progeroid mandibuloacral dysplasia, Mandibuloacral dysplasia progeroid syndrome |
| RS139259793 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS139259804 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis Imperfecta |
| RS139260335 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, COL6A3-related disorder |
| RS1392604380 |
CIROP
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1392614291 |
TMEM127
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary cancer-predisposing syndrome |
| RS139261571 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Inborn genetic diseases |
| RS139262486 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS139263114 |
ASB10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1392631759 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS139263189 |
TCIRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 1, Inborn genetic diseases |
| RS139263450 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Ellis-van Creveld syndrome |
| RS1392635342 |
CC2D2A
|
Health Risk |
Likely pathogenic |
Joubert syndrome 9, Joubert syndrome 9 |
| RS139263536 |
IVNS1ABP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139263608 |
F12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1392638187 |
SLC18A2
|
Health Risk |
Likely pathogenic |
Brain dopamine-serotonin vesicular transport disease, Brain dopamine-serotonin vesicular transport disease |
| RS1392647178 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS139264724 |
FBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS139264769 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 1 diabetes mellitus 2, Hyperproinsulinemia |
| RS139264859 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS139265251 |
WAS
|
Health Risk |
Pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS139265462 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
Moyamoya disease 2, Moyamoya disease 2 |
| RS139265757 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS1392661120 |
DNAI1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS139266382 |
FAM161A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 28 |
| RS139266578 |
EGF
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal hypomagnesemia 4, Renal hypomagnesemia 4 |
| RS139266750 |
IL2RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS139267208 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS139267495 |
SUMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple sulfatase deficiency, Inborn genetic diseases |
| RS139268254 |
FAH
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinemia type I, Tyrosinemia type I |
| RS139270058 |
SLC9A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1392702424 |
TMC6
|
Health Risk |
Pathogenic |
Epidermodysplasia verruciformis, Epidermodysplasia verruciformis |
| RS139270936 |
SLC7A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS1392709495 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinitis pigmentosa 40 |
| RS139271648 |
PARP10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139272198 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary xanthinuria type 1, Inborn genetic diseases |
| RS139272614 |
GNPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhizomelic chondrodysplasia punctata type 2, GNPAT-related disorder |
| RS139272628 |
GRN
|
Health Risk |
Conflicting classifications of pathogenicity |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS139273379 |
TNS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139274834 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1392755260 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS139277089 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1392778905 |
APC
|
Health Risk |
Pathogenic |
Familial multiple polyposis syndrome, Familial adenomatous polyposis 1 |
| RS139278612 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS1392791154 |
ABCC2
|
Health Risk |
Likely pathogenic |
— |
| RS139279260 |
CYP27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestanol storage disease, Cardiovascular phenotype |
| RS1392795567 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 1, Maturity-onset diabetes of the young |
| RS139281553 |
HJV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS139281637 |
CASQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 2, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS139281846 |
MAN2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of alpha-mannosidase, MAN2B1-related disorder |
| RS139282177 |
POLG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139282720 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolman disease, Cardiovascular phenotype |
| RS139283183 |
UQCRB
|
Health Risk |
Conflicting classifications of pathogenicity |
UQCRB-related disorder, Mitochondrial complex III deficiency nuclear type 3 |
| RS1392832988 |
LOC126806428;TTN
|
Health Risk |
Pathogenic |
TTN-related disorder, TTN-related disorder |
| RS1392844393 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Knobloch syndrome, Knobloch syndrome |
| RS139285603 |
CAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139286030 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS1392860800 |
SDHA
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Lung cancer |
| RS139286118 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1392865152 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS139286519 |
EXOSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome, Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome |
| RS139286618 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypothyroidism due to TSH receptor mutations, Familial hyperthyroidism due to mutations in TSH receptor |
| RS139286639 |
KATNIP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1392868365 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS139287033 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |